Miriam Contreras 

University of Barcelona

Miriam is a biologist (University of Salamanca, 2013). She performed her Master degree in Molecular Biology and Genetics at the University of Iceland (2015). During her Master, she was also working for Stofnfiskur Company as a research scientist. She is a very active girl who loves sports, food and people. She is passionate about travelling and music.

Miriam´s secondment
Miriam just arrived from her secondment at the Goethe University Medical School in Frankfrut am Main. The secondment lasted 2 intensive months. She is very happy with the results obtained from her experiments and she mentioned that it was a wonderful opportunity to increase her knowledge in many protocols and techniques. For instance, hypoxia environment, work with AML primary cells, CRISPR/Cas technology, resistant cell lines, etc. She pointed out the group-work in the lab and the good reception the group had when she arrived. She said: “Everybody helped me a lot. I could not be happier”.  In addition, she had the chance to travel with the lab group to Rothenfels, where they hiked, had a nice barbecue and sleep over in a beautiful hostel inside a castle. Despite of the few weekends free of work, she made the most of them and travel around Germany to meet friends, learn the German culture and gastronomy (very important). 

The Serve labs view 
Miriam came to Frankfurt and joined the Serve lab for two hot German summer month. First, we would like to thank her for the wonderful time we had with her – she is an intelligent, funny and open-minded person and completely integrated into our team and thus became, with no effort, a valued colleague and friend. From the first day on she worked hard and contributed practically and theoretically to many scientific projects running in our lab. All techniques she was trained in she put into action successfully – ranging from the application of the CRISPR/Cas9 technology and other genome editing tools to generate resistant AML cell lines by knockout or overexpression of specific proteins known to trigger chemotherapy resistance, preparation of samples of cytarabine and doxorubicine-resistant acute myeloid leukemia (AML) cell lines to subsequently be measured in Barcelona or the isolation and cultivation of primary acute myeloid leukemia blasts in a hypoxic microenvironment. Not only she came here for training, also we did learn a lot from her way of thinking and discussing and her way of performing experiments. We are very sad that the time went by so fast – but we are happy to see her soon again for the mid-term meeting in September 2017 in Brussels. You are always welcome in Frankfurt!

© HaemMetabolome 2016